Literature DB >> 17172117

[The analysis of plasma homocysteine among 1020 residents in community].

Ming-hui Guo1, Jia-xing Huang, Rui-jin Lin, Ying Zhang, Ya-li Chen.   

Abstract

OBJECTIVE: To study the plasma homocysteine (Hcy) distributive characteristics in different sex and age groups of the community residents in Guangdong, and to analyze its associated factors as well as its effects on cerebral artery stenosis.
METHODS: In this study, we presented data concerning 2500 residents who had undergone a systematic health checkup,including clinical and biologic examinations. Plasma was saved from 1020 residents who were asymptomatic but having TCD examination. Hcy concentration was measured by fluorescence ration biochemical assay kit.
RESULTS: The average plasma Hcy levels of males (15.0 micromol/L+/-5.8 micromol/L) were significantly higher than those of females (12.4 micromol/L-I 3.9 micromol/L, P< 0.05). Hcy level increased parallel with age. The prevalence rate of hyperhomocysteinemia in males (47.2%) was higher than in females (23.2%). Hcy levels in MCA stenosis group (18.3 micromol/L+ 5.3 micromol/L) were significantly higher than that in control group (12.9 micromol/L+/- 4.6 micromol/L, P< 0.05). Based on logistic regression analysis, Hcy was only associated with sex and age, but not with blood lipids etc.
CONCLUSION: Hcy levels were different in sex and age groups which emerged as independent predictors of hyperhomocysteinemia but had no association with blood lipids in the community residents, suggesting that hyperhomocysteinemia might worsen cerebral artery stenosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17172117

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  1 in total

1.  Effect of enalapril on plasma homocysteine levels in patients with essential hypertension.

Authors:  Fang-fang Fan; Yong Huo; Xu Wang; Xin Xu; Bin-yan Wang; Xi-ping Xu; Jian-ping Li
Journal:  J Zhejiang Univ Sci B       Date:  2010-08       Impact factor: 3.066

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.